EUCOPE News by Tag — Rare Disease

Filtered by Tag: Rare Disease

Events & Meetings / News - July 28, 2021

Event Report: EUCOPE/FranceBiotech roundtable ‘OMP Regulation Revision, perspectives of the French rare disease community’

EUCOPE, in partnership with FranceBiotech, hosted a roundtable on the revision of the orphan medicine and paediatric regulations with French stakeholders on 30 June. The orphan and paediatric legislation has considerably accelerated research efforts over the last two decades and has contributed to the development… read more

Partnerships - March 25, 2021

OrphVal

Working group of European rare disease experts developed  nine principles to foster greater consistency in Value Assessment and Funding Process in rare diseases. The group explored the pricing and reimbursement systems for OMPs in selected European countries to analyse where they align with or diverge from… read more

Partnerships - March 25, 2021

RWE4Decisions

Multi-stakeholder initiative commissioned by the Belgian National Institute of Health and Disability Insurance (INAMI-RIZIV) aimed at fostering stakeholders’ agreement of what real-world data (RWD) can be collected for highly innovative technologies, to generate real-world evidence (RWE) that informs decisions by healthcare systems, clinicians and patients…. read more

Partnerships - March 25, 2021

European Expert Group on OD Incentives

Multidisciplinary expert group including researchers, academia, patient representatives, investors and industry Input to strengthen the OMP Incentives Environment in Europe focusing on addressing unmet needs and supporting delivery of continued innovation where treatments exist; finding ways to optimise and accelerate OD regulatory pathways and identifying… read more